APHL in partnership with the Association for Molecular Pathology (AMP) is convening this webinar to provide information on the laboratory response to the current outbreak of Mpox virus. Speakers will address the current state of the response, the science of poxviruses such as Mpox, the development and use of laboratory tests for diagnoses as well as biosafety considerations for testing.
Speakers
Alexander L. Greninger, MD, PhD., MS, M.Phil.
Assistant director, University of Washington Medicine Clinical Virology Laboratory, Assistant Professor, Laboratory Medicine
Christina Hutson, Ph.D., MS.
branch chief, Poxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention
Jonathan Mermin, MD, MPH.
Incident manager, Monkeypox Response, Director of the National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Rear Admiral, U,S, Public Health Service
Sandra C. Smole, PhD.
Director, Massachusetts State Public Health Laboratory, Bureau of Infectious Disease and Laboratory Sciences, Department of Public Health
Timothy Stenzel, MD, PhD.
Director, Office of In Vitro Diagnostics and Radiological Health, U.S. Food and Drug Administration
Moderators
Allen Bateman, Ph.D., D (ABMM)
Association of Molecular Pathology Directors, director, Communicable Disease Division, Wisconsin State Laboratory of Hygiene
Andrew C. Cannons, Ph.D., HCLD (ABB)
chair, Public Health Preparedness and Response Committee, APHL, laboratory director, Bureau of Public Health Laboratories –Tampa, Division of Disease Control and Health Protection, Florida Department of Health
